Related Experiment Video
Updated: Jun 6, 2026
06:07
Exploring Infant Sensitivity to Visual Language using Eye Tracking and the Preferential Looking Paradigm
Published on: May 15, 2019
Clinical research in newborn infants: difficulties and specificity
Isabelle Ligi1, Farid Boubred, Isabelle Grandvuillemin
1Division of Neonatology, La Conception Hospital, Assistance Publique-Hôpitaux de Marseille and Faculté de Médecine, Université de la Méditerranée, Marseille, France.
European Journal of Clinical Pharmacology
|November 19, 2010
Summary
Conducting clinical trials in neonates requires careful consideration of unique physiological and ethical challenges. This review details these specific constraints and European Commission recommendations for safe and ethical neonatal research.
Area of Science:
- Neonatal research
- Clinical pharmacology
- Pediatric drug development
Background:
- Clinical trials are crucial for assessing drug efficacy and safety in neonates.
- Neonatal physiology presents unique challenges for clinical research.
- Ethical considerations are paramount in pediatric drug studies.
Purpose of the Study:
- To review the specific constraints in neonatal research studies.
- To identify obstacles in designing and conducting neonatal clinical trials.
- To highlight recent recommendations for ethical neonatal research.
Main Methods:
- Literature review.
- Synthesis of authors' expert opinions.
- Analysis of European Commission guidelines.
Main Results:
- Specific neonatal characteristics that pose challenges to research are detailed.
- Obstacles in neonatal study design and proposals are identified.
- Recommendations for safe and ethical research are presented.
Conclusions:
- Understanding neonatal specificities is key to overcoming research obstacles.
- European Commission recommendations provide a framework for ethical neonatal studies.
- Implementing these recommendations can improve the quality and safety of neonatal drug evaluation.
